Wuhan Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wuhan Yu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Weihua Yu
Chongqing Medical University
2 shared publications - Yang Lü
The First Affiliated Hospital of Chongqing Medical University
2 shared publications - Zhangjing Deng
Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
2 shared publications - Fuxin Zhong
Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication - Jiani Wu
Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication - Jianwei Shou
Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication
Latest Publications
- 17 September 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 108 (2) , 733-745
Education as a domain-specific moderator: Shaping the impact of cerebral structural changes on clinical manifestations in Alzheimer's disease
Background: Global cognitive performance is influenced by change in cerebral structure and educational background. However, little is known about how education moderates the impact of cerebral structural changes on different cognitive domains and other non-cognitive dysfunction across the clinical stages of Alzheimer's disease (AD). Objective: To explore the moderating effect of education on relationship between cerebral structure and various clinical manifestations across the AD continuum, ranging from mild cognitive impairment (MCI) to AD. Methods: This cross-sectional study included data of 570 patients diagnosed with MCI or AD. The total years of education were used as a moderating variable, and AD-related cerebral structure changes were assessed through visual ratings on magnetic resonance imaging (MRI). Multiple linear regressions were performed to examine whether education moderated the association between cerebral structure and clinical characteristics at different diagnostic stages of AD. Results: Patients with higher levels of education demonstrated better cognitive ability, enhanced activities of daily living, and milder neuropsychiatric symptoms. The moderating effect of education was most prominent during the MCI or early AD stages, showing cognitive domain-specific effects. In these stage, education alleviated the negative impacts of neurostructural changes on immediate learning but exacerbated the detrimental effects of cerebral structural changes on speed/executive function, language, and episodic memory. Conclusions: Education serve as a moderator in relationship between cerebral structure and various clinical characteristics. The moderating effect of education is domain-specific and most noticeable in the early stage of AD.
- 17 September 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 108 (2) , 733-745
Education as a domain-specific moderator: Shaping the impact of cerebral structural changes on clinical manifestations in Alzheimer's disease
Background: Global cognitive performance is influenced by change in cerebral structure and educational background. However, little is known about how education moderates the impact of cerebral structural changes on different cognitive domains and other non-cognitive dysfunction across the clinical stages of Alzheimer's disease (AD). Objective: To explore the moderating effect of education on relationship between cerebral structure and various clinical manifestations across the AD continuum, ranging from mild cognitive impairment (MCI) to AD. Methods: This cross-sectional study included data of 570 patients diagnosed with MCI or AD. The total years of education were used as a moderating variable, and AD-related cerebral structure changes were assessed through visual ratings on magnetic resonance imaging (MRI). Multiple linear regressions were performed to examine whether education moderated the association between cerebral structure and clinical characteristics at different diagnostic stages of AD. Results: Patients with higher levels of education demonstrated better cognitive ability, enhanced activities of daily living, and milder neuropsychiatric symptoms. The moderating effect of education was most prominent during the MCI or early AD stages, showing cognitive domain-specific effects. In these stage, education alleviated the negative impacts of neurostructural changes on immediate learning but exacerbated the detrimental effects of cerebral structural changes on speed/executive function, language, and episodic memory. Conclusions: Education serve as a moderator in relationship between cerebral structure and various clinical characteristics. The moderating effect of education is domain-specific and most noticeable in the early stage of AD.
- Open Access
- 12 February 2024
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 44 (1) , 1-17
Disease-Associated Neurotoxic Astrocyte Markers in Alzheimer Disease Based on Integrative Single-Nucleus RNA Sequencing
Alzheimer disease (AD) is an irreversible neurodegenerative disease, and astrocytes play a key role in its onset and progression. The aim of this study is to analyze the characteristics of neurotoxic astrocytes and identify novel molecular targets for slowing down the progression of AD. Single-nucleus RNA sequencing (snRNA-seq) data were analyzed from various AD cohorts comprising about 210,654 cells from 53 brain tissue. By integrating snRNA-seq data with bulk RNA-seq data, crucial astrocyte types and genes associated with the prognosis of patients with AD were identified. The expression of neurotoxic astrocyte markers was validated using 5 × FAD and wild-type (WT) mouse models, combined with experiments such as western blot, quantitative real-time PCR (qRT-PCR), and immunofluorescence. A group of neurotoxic astrocytes closely related to AD pathology was identified, which were involved in inflammatory responses and pathways related to neuron survival. Combining snRNA and bulk tissue data, ZEP36L, AEBP1, WWTR1, PHYHD1, DST and RASL12 were identified as toxic astrocyte markers closely related to disease severity, significantly elevated in brain tissues of 5 × FAD mice and primary astrocytes treated with Aβ. Among them, WWTR1 was significantly increased in astrocytes of 5 × FAD mice, driving astrocyte inflammatory responses, and has been identified as an important marker of neurotoxic astrocytes. snRNA-seq analysis reveals the biological functions of neurotoxic astrocytes. Six genes related to AD pathology were identified and validated, among which WWTR1 may be a novel marker of neurotoxic astrocytes.
- 12 February 2024
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 44 (1) , 1-17
Open AccessDisease-Associated Neurotoxic Astrocyte Markers in Alzheimer Disease Based on Integrative Single-Nucleus RNA Sequencing
Alzheimer disease (AD) is an irreversible neurodegenerative disease, and astrocytes play a key role in its onset and progression. The aim of this study is to analyze the characteristics of neurotoxic astrocytes and identify novel molecular targets for slowing down the progression of AD. Single-nucleus RNA sequencing (snRNA-seq) data were analyzed from various AD cohorts comprising about 210,654 cells from 53 brain tissue. By integrating snRNA-seq data with bulk RNA-seq data, crucial astrocyte types and genes associated with the prognosis of patients with AD were identified. The expression of neurotoxic astrocyte markers was validated using 5 × FAD and wild-type (WT) mouse models, combined with experiments such as western blot, quantitative real-time PCR (qRT-PCR), and immunofluorescence. A group of neurotoxic astrocytes closely related to AD pathology was identified, which were involved in inflammatory responses and pathways related to neuron survival. Combining snRNA and bulk tissue data, ZEP36L, AEBP1, WWTR1, PHYHD1, DST and RASL12 were identified as toxic astrocyte markers closely related to disease severity, significantly elevated in brain tissues of 5 × FAD mice and primary astrocytes treated with Aβ. Among them, WWTR1 was significantly increased in astrocytes of 5 × FAD mice, driving astrocyte inflammatory responses, and has been identified as an important marker of neurotoxic astrocytes. snRNA-seq analysis reveals the biological functions of neurotoxic astrocytes. Six genes related to AD pathology were identified and validated, among which WWTR1 may be a novel marker of neurotoxic astrocytes.